{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:28:50Z","timestamp":1790710130288,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"am","delay-in-days":299,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.intimp.2022.108558","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T10:30:03Z","timestamp":1643106603000},"page":"108558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Anti-allergic, anti-asthmatic and anti-inflammatory effects of an oxazolidinone hydroxamic acid derivative (PH-251) \u2013 A novel dual inhibitor of 5-lipoxygenase and mast cell degranulation"],"prefix":"10.1016","volume":"105","author":[{"given":"Charles I.","family":"Ezeamuzie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muddanna S.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Z.","family":"El-Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Philip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oludotun A.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.108558_b0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejmech.2017.10.020","article-title":"Recent advances in the search for 5-lipoxygenase inhibitors for the treatment of asthma","volume":"153","author":"Bruno","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2022.108558_b0010","doi-asserted-by":"crossref","first-page":"2432958","DOI":"10.1155\/2017\/2432958","article-title":"Role of cysteinyl leukotrienes in the pathogenesis and progression of cardiovascular diseases","volume":"2017","author":"Colazzo","year":"2017","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.intimp.2022.108558_b0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/039463201102400105","article-title":"Effect of inhibition of the ubiquitin-proteasome-system and I\u03baB kinase on airway inflammation and hyper-responsiveness in a murine model of asthma","volume":"24","author":"El-Hashim","year":"2011","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108558_b0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1165\/rcmb.4532","article-title":"Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse","volume":"28","author":"Eum","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108558_b0025","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1124\/jpet.114.213751","article-title":"Antiallergic and antiasthmatic effects of a novel enhydrazinone ester (CEE-1): inhibition of activation of both mast cells and eosinophils","volume":"350","author":"Ezeamuzie","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2022.108558_b0030","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic diseases","volume":"18","author":"Galli","year":"2012","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.intimp.2022.108558_b0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.18176\/jiaci.0327","article-title":"Mast cells as key players in allergy and inflammation","volume":"28","author":"Gonz\u00e1lez-de-Olano","year":"2018","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.intimp.2022.108558_b0040","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1021\/jm401557w","article-title":"Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficacy in vivo","volume":"56","author":"Hanke","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2022.108558_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.595498","article-title":"Eicosanoids in Cancer: New Roles in Immunoregulation","volume":"11","author":"Johnson","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2022.108558_b0050","first-page":"615","article-title":"Interactions between leukotrienes and histamine in the anaphylactic contraction of guinea pig lung parenchyma","volume":"271","author":"Jonsson","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2022.108558_b0055","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.3390\/ijms20143580","article-title":"The role of leukotrienes as potential therapeutic targets in allergic disorders","volume":"20","author":"Jo-Watanabe","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2022.108558_b0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/MCP.0000000000000224","article-title":"Airway inflammation in asthma: key players beyond the Th2 pathway","volume":"22","author":"KleinJan","year":"2016","journal-title":"Curr. Opin. Pul. Med."},{"issue":"25","key":"10.1016\/j.intimp.2022.108558_b0065","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJM199012203232506","article-title":"Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor","volume":"323","author":"Knapp","year":"1990","journal-title":"New Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.108558_b0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.alit.2014.09.001","article-title":"The role of leukotrienes in allergic diseases","volume":"64","author":"Liu","year":"2015","journal-title":"Allergol. Int."},{"key":"10.1016\/j.intimp.2022.108558_b0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1872213X14666200130095040","article-title":"The Role of leukotrienes inhibitors in the management of chronic inflammatory diseases","volume":"14","author":"Meshram","year":"2020","journal-title":"Recent Pat. Inflamm. Allergy Drug Discov."},{"key":"10.1016\/j.intimp.2022.108558_b0080","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.trsl.2016.02.011","article-title":"Emerging concepts: mast cell involvement in allergic diseases","volume":"174","author":"Modena","year":"2016","journal-title":"Transl. Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.108558_b0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12634","article-title":"Mast cells as sources of cytokines, chemokines and growth factors","volume":"282","author":"Mukai","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2022.108558_b0090","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2174\/0929867023369402","article-title":"Hydroxamic acid as pharmacological agents: An update","volume":"9","author":"Muri","year":"2002","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2022.108558_b0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ccm.2018.10.014","article-title":"Pro-inflammatory Pathways in the pathogenesis of asthma","volume":"40","author":"Peebles","year":"2019","journal-title":"Clin. Chest Med."},{"issue":"18","key":"10.1016\/j.intimp.2022.108558_b0100","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Peters-Golden","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.108558_b0105","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1080\/14756366.2020.1786082","article-title":"Synthesis and structure-activity relationships of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives as 5-lipoxygenase inhibitors","volume":"35","author":"Phillips","year":"2020","journal-title":"J. Enz. Inhib. Med. Chem."},{"key":"10.1016\/j.intimp.2022.108558_b0110","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejmech.2013.05.041","article-title":"Synthesis and antibacterial activities of N-substituted-gylcinyl 1H\u20131,2,3-triazolyl oxazolidinones","volume":"66","author":"Phillips","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2022.108558_b0115","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejphar.2018.10.040","article-title":"A novel therapeutic potential of cysteinyl leukotrienes and their receptors in the neurological complications associated with Alzheimer\u2019s disease","volume":"842","author":"Rahman","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2022.108558_b0120","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ejmech.2007.05.003","article-title":"Synthesis and in vitro antibacterial activities of novel oxazolidinones","volume":"43","author":"Srivastava","year":"2008","journal-title":"Eur. J. Med. Chem."},{"issue":"5 suppl. 68","key":"10.1016\/j.intimp.2022.108558_b0125","first-page":"S13","article-title":"Pharmacodynamics of glucocorticoids","volume":"29","author":"Strehl","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2022.108558_b0130","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1476-5381.1988.tb11557.x","article-title":"Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex-vivo","volume":"94","author":"Tateson","year":"1988","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2022.108558_b0135","doi-asserted-by":"crossref","first-page":"788","DOI":"10.4049\/jimmunol.127.2.788","article-title":"Long-term in vitro culture of murine mast cells. I. Description of a growth factor-dependent culture technique","volume":"127","author":"Tertian","year":"1981","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2022.108558_b0140","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1080\/17476348.2019.1670640","article-title":"Asthma pharmacotherapy: an update on leukotriene treatments","volume":"13","author":"Trinh","year":"2019","journal-title":"Expert. Rev. Respir. Med."},{"key":"10.1016\/j.intimp.2022.108558_b0145","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.bjp.0703044","article-title":"Inhibition by troglitazone of the antigen-induced production of leukotrienes in immunoglobulin E-sensitized RBL-2H3 cells","volume":"129","author":"Yamashita","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2022.108558_b0150","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejphar.2015.05.071","article-title":"Mast cell stabilizers","volume":"778","author":"Zhang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2022.108558_b0151","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1164\/ajrccm.155.6.9196086","article-title":"Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics.","volume":"155","author":"Roquet","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692200042X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692200042X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T20:17:09Z","timestamp":1730837829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692200042X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":31,"alternative-id":["S156757692200042X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108558","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-allergic, anti-asthmatic and anti-inflammatory effects of an oxazolidinone hydroxamic acid derivative (PH-251) \u2013 A novel dual inhibitor of 5-lipoxygenase and mast cell degranulation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108558"}}